Evidence map›Paper›PMID 39550438›Full record

ArticleScientific reports2024

Safety of local thermal ablation in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia.

Feiyu Zhao, Tianlan Zhang, Qinna Yang, Xiaoming Zhang, Fan Yang, Niansong Qian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feiyu Zhao *Department of Thoracic Oncology, Senior Department of Respiratory and Critical CareMedicine, the Eighth Medical Center of PLA General Hospital, A17, Heishanhu Road, Haidian District, Beijing, 100091, China.
Tianlan Zhang *Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, No. 8 Dongda Street, Fengtai District, Beijing, 100071, China.
Qinna Yang *Department of Thoracic Oncology, Senior Department of Respiratory and Critical CareMedicine, the Eighth Medical Center of PLA General Hospital, A17, Heishanhu Road, Haidian District, Beijing, 100091, China.
Xiaoming ZhangDepartment of Thoracic Oncology, Senior Department of Respiratory and Critical CareMedicine, the Eighth Medical Center of PLA General Hospital, A17, Heishanhu Road, Haidian District, Beijing, 100091, China.
Fan YangSenior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, No. 8 Dongda Street, Fengtai District, Beijing, 100071, China. yangfanqk567@163.com.
Niansong QianDepartment of Thoracic Oncology, Senior Department of Respiratory and Critical CareMedicine, the Eighth Medical Center of PLA General Hospital, A17, Heishanhu Road, Haidian District, Beijing, 100091, China. qianniansong1@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generally, invasive treatment is contraindication for patients with severe thrombocytopenia, because it may increase risk of bleeding. However, many early hepatocellular carcinoma (HCC) patients with cirrhosis have platelet counts (PC) less than 50 × 10

Indexed as

Carcinoma, HepatocellularLiver CirrhosisLiver NeoplasmsThrombocytopeniaAdultAgedCatheter AblationFemaleHumansMaleMiddle AgedPlatelet CountRetrospective StudiesRisk FactorsHepatocellular carcinomaMicrowave ablationPostoperative hemorrhageRadiofrequency ablationThrombocytopenia

Identifiers

PMID39550438
PMCPMC11569221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.